terlipressin has been researched along with methylene blue in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Almeida, JA; Bihari, D; Cranney, GB; Galhenage, S; Kim, R; Liu, J; Riordan, SM; Thomas, PS; Wegner, EA | 1 |
Belletti, A; Finco, G; Fominskiy, E; Hajjar, LA; Landoni, G; Monaco, F; Musu, M; Pasin, L; Saleh, O; Silvetti, S; Zangrillo, A | 1 |
Russell, JA | 1 |
Allam, R; Awad, H; Ibrahim, M; Ismail, R; Shehata, B; Youssef, O | 1 |
2 review(s) available for terlipressin and methylene blue
Article | Year |
---|---|
Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A Systematic Review and Meta-Analysis of Randomized Trials.
Topics: Databases, Factual; Humans; Lypressin; Methylene Blue; Randomized Controlled Trials as Topic; Sepsis; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2015 |
Vasopressor therapy in critically ill patients with shock.
Topics: Angiotensin II; Critical Illness; Dopamine; Epinephrine; Humans; Methylene Blue; Norepinephrine; Phenylephrine; Shock; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2019 |
1 trial(s) available for terlipressin and methylene blue
Article | Year |
---|---|
Methylene blue versus vasopressin analog for refractory septic shock in the preterm neonate: A randomized controlled trial.
Topics: Hemodynamics; Humans; Infant; Infant, Newborn; Infant, Premature; Methylene Blue; Shock, Septic; Terlipressin; Vasoconstrictor Agents; Vasopressins | 2022 |
1 other study(ies) available for terlipressin and methylene blue
Article | Year |
---|---|
Deleterious effect of nitric oxide inhibition in chronic hepatopulmonary syndrome.
Topics: Antihypertensive Agents; Blood Pressure; Chronic Disease; Curcumin; Cyclic GMP; Echocardiography; Female; Hepatopulmonary Syndrome; Humans; Lypressin; Methylene Blue; Middle Aged; Nitric Oxide; Terlipressin; Treatment Failure; Vascular Resistance | 2007 |